baber/WOPTO huggingface dataset:
Patent AU-2010258047-A1 (AU)
Title: Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens
Inventor: CHIL-YONG KANG
IPC: A61P37/04
Filed: 2010-06-08
Abstract: Immunization platforms, immunization regimes and medicaments useful for inducing an immune response in a mammal and preventing or treating a pathogenic infection in a mammal, wherein said immunization platforms and medicaments comprise a recombinant vesicular stomatitis virus (VSV) of one serotype and a rVSV of another serotype and are used in a prime-boost immunization regime In aspects of the invention one VSV serotype is Indiana and the other VSV serotype is New Jersey.
Patent AU-2010273319-A1 (AU)
Title: Drug selection for gastric cancer therapy using antibody-based arrays
Inventor: SINGH SHARAT
IPC: G01N33/574
Filed: 2010-07-15
Abstract: The present invention provides methods for selecting a suitable anticancer therapy, and for identifying and predicting response for the treatment of a gastric cancer.
Patent AU-2010285068-A1 (AU)
Title: A nutritional composition comprising Lactococcus strains and reducing allergy symptoms, especially in infants and children.
Inventor: HOLVOET SEBASTIEN
IPC: A23L33/00
Filed: 2010-08-13
Abstract: A complete nutritional composition comprising Lactococcus strains or probiotic is provided for reducing the symptoms of allergies in different groups of patients such as allergies originating from food allergens in young children or infants and respiratory allergens in children,adults and household pets. Preferably the composition reduces symptoms of allergies (secondary prevention) while not significantly affecting sensitization (primary prevention). The composition comprises a probiotic of the genus Lactococcus.
Patent AU-2010292554-A1 (AU)
Title: Osteolysis treatment
Inventor: HOEPPNER JACY
IPC: A61K38/48
Filed: 2010-08-26
Abstract: Methods and treatments for osteolysis employing interleukin-1 receptor antagonist (IL-1ra). Activating production of interleukin-1 receptor antagonist includes incubating adipose tissue, adipocytes, whole blood, platelet rich plasma, and/or isolated white blood cells with polyacrylamide beads to produce a solution rich in interleukin-1 receptor antagonist. Activating the production of interleukin-1 receptor antagonist includes using an implantable device loaded with adipose tissue, adipocytes, whole blood, platelet rich plasma, and/or isolated white blood cells. Methods for treating osteolysis at the site of an artificial joint in a patient include administering and/or inserting the solution rich in interleukin-1 receptor antagonist and/or the implantable device, respectively.
Patent AU-2010315929-A1 (AU)
Title: Modular connector plug for high speed applications
Inventor: GUTTER DAVID HENRY
IPC: H01R24/58
Filed: 2010-10-28
Abstract: A modular connector plug for high speed applications includes a wire guide filter at least partially situated in the conductor-receiving cavity of the housing of the plug. The wire guide filter includes an impedance containing portion comprising a longitudinally extending body having a plurality of longitudinally extending passageways and an internal cable guide portion comprising a longitudinally extending body defining a plurality of longitudinally extending passageways.
Patent AU-2010319602-A1 (AU)
Title: Synergistic muscle activation device
Inventor: FAHEY BRIAN J
IPC: A61N1/36
Filed: 2010-11-10
Abstract: Systems and methods of use for guiding the flow of energy through a subject to stimulate tissue.
Patent AU-2010355940-A1 (AU)
Title: Quick positioning method and device of multicycle and multiuser
Inventor: SONG NA
IPC: H04W4/08
Filed: 2010-11-18
Abstract: A quick positioning method and device of multicycle and multiuser are provided, and the method includes that: a processing index is created for each attribute of a user in a base station, wherein the identical attribute with the same transmission cycle and transmission offset shares a processing index; when a user accesses the base station, the user is mounted to a corresponding processing index according to the attribute of the user and the transmission cycle and transmission offset of the attribute; by inquiring the corresponding processing index of the present moment, the base station demodulates the attribute of the user who is mounted to the processing index. By the present invention, the effect of hitting the target quickly is achieved, the processing time is saved, the processing efficiency is improved, and the processing time delay of the whole link is shortened.
Patent AU-2010356339-A1 (AU)
Title: Stable antiseptic compositions and methods
Inventor: SCHOLZ MATTHEW T
IPC: A61K31/13
Filed: 2010-06-29
Abstract: Provided are methods of improving the stability of antiseptic compositions that include elemental iodine and certain hydroxycarboxylic acids, as well as stable, ready to use antiseptic compositions suitable for use in the nose and anterior nares.
Patent WO-2012031328-A1 (WO)
Title: Traitements d'un abus de substance et d'une addiction
Inventor: GUNDLACH ANDREW LAWRENCE
IPC: A61P25/30
Filed: 2011-09-08
Abstract: La présente invention a pour objet des méthodes de prévention ou d'inhibition de comportements négatifs associés à un abus de substance ou à une addiction, comme une utilisation de substance (auto-administration) ou un comportement de recherche de substance, lesdits procédés comprenant l'administration aux sujets en ayant besoin d'un antagoniste du récepteur de la relaxine 3. Dans des modes de réalisation particuliers, le récepteur de la relaxine 3 est le récepteur RXFP3, et dans des modes de réalisation particuliers, l'antagoniste est un polypeptide modifié de relaxine, éventuellement un antagoniste sélectif du RXFP3.
Patent AU-2011201186-A1 (AU)
Title: Surgical console and hand-held surgical device
Inventor: DONALD MALINOUSKAS
IPC: A61B17/068
Filed: 2011-03-16
Abstract: SURGICAL CONSOLE AND HAND-HELD SURGICAL DEVICE Abstract A surgical system (10) and method includes a surgical instrument (200) 5 configured to wirelessly transmit identifying data specific to the surgical instrument and a console (100) configured to receive the identifying data. The console is configured to register the surgical instrument based on the identifying data, establish a wireless two way communication link between the surgical instrument and the console, receive at least one of operational data and commands from the surgical instrument, and provide io operational feedback data to a user of the surgical instrument during an operation of the surgical instrument based on the at least one of operational data and commands. VIDEO S-VIDEO S ..9. 35 1d 150 130 135 140 145
Patent AU-2011209506-A1 (AU)
Title: Method for producing interferon alpha 5
Inventor: BUMELIS VLADAS ALGIRDAS
IPC: C12N1/38
Filed: 2011-01-31
Abstract: The invention relates to a method for producing an interferon alpha 5 protein (IFNa5) by expression in a host cell producing IFNa5, which minimises the inclusion of an extra residue of methionine in the N-terminal end of the polypeptide chain and the generation of the oxidised species thereof. The IFNa5 protein can be purified using an effective method to provide a biologically active IFNa.
Patent AU-2011211306-A1 (AU)
Title: Di - substituted pyridine derivatives as anticancers
Inventor: TAKASU HIDEKI
IPC: C07D401/12
Filed: 2011-01-28
Abstract: The present invention provides a novel compound having an excellent antitumor effect. The compound of the present invention is represented by the following general formula (1) wherein R and R are aryl or the like; A is lower alkylene; Ring X is optionally substituted arylene; E is bond or lower alkenylene; Ring Y is optionally substituted heterocycloalkylene containing one or more nitrogen atoms, one of which is attached to the adjacent carbonyl group; G is -NH-G-, -N(lower alkyl)-G-, -NH-CH-G-, -N(lower alkyl)-CH-G- or -CH-G-, [wherein G binds to R, G-R is bond-R, phenylene-G-R, phenylene-G-O-R, phenylene-G-NH-R, phenylene-G-N(lower alkyl)-R or quinolinediyl-O-R, the phenylene of said phenylene-cotnaining groups being optionally substituted with one or more substituents; G-R is -O-lower alkylene-R or the like; G-O- is lower alkylene-O- or the like; G is lower alkylene; G is lower alkylene].
Patent AU-2011212071-A1 (AU)
Title: Methods for the separation of HCl from a carbohydrate and compositions produced thereby
Inventor: EYAL AHARON
IPC: B01D53/14
Filed: 2011-02-06
Abstract: The present invention provides an organic phase composition comprising: (a) a first solvent (S1 ) characterized by a water solubility of less than 10% and by at least one of (a1 ) having a polarity related component of Hoy's cohesion parameter (delta-P) between 5 and 10 MPa and (b1 ) having a Hydrogen bonding related component of Hoy's cohesion parameter (delta- H) between 5 and 20 MPa; (b) a second solvent (S2) characterized by a water solubility of at least 30% and by at least one of (a2) having a delta-P greater than 8 MPaand (b2) having a delta-H greater than 12 MPa; (c) water; (d) HCI; and (e) a carbohydrate.
Patent AU-2011252864-A1 (AU)
Title: Improved complement receptor 2 (CR2) targeting groups
Inventor: KOVACS JAMES
IPC: C07K14/705
Filed: 2011-05-13
Abstract: Provided herein are compositions and methods directed to soluble proteins which can selectively deliver modulators of complement activity. Targeted delivery of these modulators is accomplished by selectively mutating particular amino acids in a targeting protein portion of the composition corresponding to at least the first two N-terminal SCR domains of CR2. Depending on the particular combination of mutations introduced into the targeting portion, a complement activity modulator can be selectively delivered to particular ligands of CR2 at sites where complement system activation or suppression is desired.
Patent AU-2011254013-A1 (AU)
Title: Image processing apparatus, image processing method, and program
Inventor: FUKUNAGA MASAKAZU
IPC: G06T1/00
Filed: 2011-12-14
Abstract: Abstract An image processing apparatus includes the following elements. A receiving device (110) receives an image. An extracting device (120) extracts regions from the image received by the receiving device. A selecting device (130) selects a region from among the regions extracted by the extracting device (120) in accordance with a predetermined rule. A measuring device (140) measures luminance values of pixels contained in the region selected by the selecting device (130). An estimating device (150) estimates a function representing a degree of fog in the image received by the receiving device (110) from the luminance values of the pixels measured by the measuring device (140). An eliminating device (160) eliminates fog from the image received by the receiving device (110) on the basis of the function estimated by the estimating device (150).
Patent AU-2011265454-A1 (AU)
Title: Phonecasting systems and methods
Inventor: KAUFMAN MATTHEW
IPC: G06F7/00
Filed: 2011-12-22
Abstract: Abstract: Multimedia files, such as audio programming, are currently available to Internet users through a combination of their personal computer, an optional portable digital audio player, and an Internet connection. Many audio programs are now currently distributed over the Internet in a syndicated form known as a "podcast", allowing users to access the latest version or "episode" of the program. The disclosed systems and methods provide a convenient, publicly-accessible system for allocating and using dedicated phone numbers to enable access to these programs. A person can simply place a telephone call and listen to such syndicated or otherwise distributed audio programming through the telephone network without the use of a computer or portable digital audio player. WO 2008/052020 PCT/US2007/082315 106 104 126 .l. 00 116--122 114 DATABASE FRONTEND A 134 DOWNLOAD 116 13 RSS FEED 1 124 FIG. 1 RSS FEED 2 NETWORK SERVER PROCESSORS BRIDGE MEMORY 2042 2062 202-- PHONE CIRCUIT|I NETWORK INFO STORAGE/ PERIPHERAL INTERFCCARDi INTERFC CARD SAN CARD INTERFACE 216-- 214--- 212--- 210-- 200---"F IG . 2
Patent AU-2011265506-A1 (AU)
Title: Chemomechanical treatment fluids and methods of use
Inventor: CHOENS II ROBERT CHARLES
IPC: C09K8/584
Filed: 2011-12-22
Abstract: Docket No. 41286US Methods and systems are provided for favorably altering the chemomechanical properties of subterranean formations using treatment fluids comprising surfactants and halide salts. Methods for treating formations comprise the steps of introducing a chemomechanical treatment fluid into the formation and allowing the treatment fluid to interact with the formation to alter its petrochemical properties in various ways. Depending on the application, the chemomechanical treatment fluid may comprise a base fluid, a halide salt and an amphoteric or nonamphoter-ic surfactant where the surfactant is dissolved in the base fluid at a concentration below its critical micelle concentration. Applications of use involving the chemomechanical treatment fluids include treatment operations, secondary recovery operations, drilling operations, and any other operation that would benefit from the formation property modifications described herein. Subterranean formation properties that may to be varied by the chemomechanical treatment fluid include fracture toughness, compressive strength, and tensile strength.
Patent AU-2011272738-A1 (AU)
Title: Methods for treating post traumatic stress disorder
Inventor: BROWNSTEIN MICHAEL J
IPC: C07D205/00
Filed: 2011-07-01
Abstract: Compounds and compositions are described herein for treating post tramatic stress disorder.
Patent AU-2011286922-A1 (AU)
Title: Image processing device and image processing method
Inventor: SATO KAZUSHI
IPC: H04N7/32
Filed: 2011-07-26
Abstract: A motion vector number limit setup portion (35) of the present invention sets, according to microblock size, a maximum value for the number of motion vectors. A motion prediction/compensation portion (32) detects the optimal prediction mode, wherein the number of motion vectors does not exceed the maximum value, and generates a predictive image after compensating the motion of a reference image through the use of the motion vector of the detected optimal prediction mode. By setting, according to microblock size, a maximum value for the number of motion vectors, it is possible, when using an expanded microblock, to prevent picture quality decline or the like, with the number of motion vectors not being limited any more than necessary.
Patent AU-2011288262-A1 (AU)
Title: Therapeutic uses of microvesicles and related microRNAs
Inventor: SHIELS PAUL
IPC: A61K35/39
Filed: 2011-08-12
Abstract: The present invention provides improved methods and compositions based on microvesicles for the treatment of various diseases, disorders and conditions. In particular, the present invention encompasses the recognition that microvesicles contain specific microRNAs which may function as intercellular regulators involved in cell or tissue regeneration, remodeling, reconstruction, reprogramming or transdifferentiation. Thus, among other things, the present invention provides methods and compositions based on microvesicles and/or associated microRNAs that provide more predictable and effective therapeutic results.
Patent AU-2011297892-A1 (AU)
Title: Tamper resistant dosage form comprising an anionic polymer
Inventor: BARNSCHEID LUTZ
IPC: A61K9/20
Filed: 2011-09-01
Abstract: The invention relates to a pharmaceutical dosage form exhibiting a breaking strength of at least 500 N, said dosage form containing - a pharmacologically active ingredient (A); - a physiologically acceptable polymer (B) obtainable by polymerization of a monomer composition comprising an ethylenically unsaturated monomer bearing an anionic functional group, in protonated form or a physiologically acceptable salt thereof; - a polyalkylene oxide (C) having a weight average molecular weight of at least 200,000 g/mol, wherein the content of the polyalkylene oxide (C) is at least 20 wt.-%, based on the total weight of the dosage form; wherein the pharmacologically active ingredient (A) is present in a controlled-release matrix comprising the polymer (B) and the polyalkylene oxide (C).
Patent AU-2011298315-A1 (AU)
Title: Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
Inventor: ASWANIA OSAMA
IPC: A61K31/58
Filed: 2011-08-31
Abstract: A drug product comprising: a dry powder inhalation device containing one or more pharmaceutical compositions present therein, wherein the one or more pharmaceutical compositions comprise active ingredients (I) 4-{(1R)-2-[(6-{2-[(2,6- dichlorobenzyl)oxy]ethoxy} hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol, or a salt thereof, and (II) (6α,11ß,16α,17α)-6,9-difluoro- 17-{[(fluoromethyl)thio]carbonyl}-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien- 7-yl 2- furancarboxylate or a solvate thereof; a hygroscopic material; and a package which encompasses the dry powder inhalation device and the hygroscopic material defining an enclosed volume therein; wherein each of the active ingredients (I) and (II) are present in the same or different pharmaceutical compositions, and wherein the enclosed volume within the package exhibits a Relative Humidity of from 20% to 40%.
Patent AU-2011316550-A1 (AU)
Title: Sulphonamide compounds and methods of making and using same
Inventor: ZAHLER ROBERT
IPC: C07D209/42
Filed: 2011-10-12
Abstract: The invention provides sulphonamide compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various sulphone compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
Patent AU-2011323463-A1 (AU)
Title: Controlled discharge ostomy appliance and moldable adhesive wafer
Inventor: TSAI MINGLIANG LAWRENCE
IPC: A61F5/445
Filed: 2011-11-02
Abstract: A controlled discharge ostomy appliance is described for use with an adhesive body fitment. The body fitment comprises an adhesive wafer having a stomal aperture that is manually shapeable by folding or rolling back a rim portion of the adhesive around the stomal aperture. At least after shaping, the adhesive presents an exposed adhesive surface portion facing towards the controlled discharge ostomy appliance.
Patent AU-2011329243-A1 (AU)
Title: Control system for a machine
Inventor: FAIVRE JOSEPH
IPC: E02F9/20
Filed: 2011-11-14
Abstract: A control system (50) and method operate to store target signals indicative of end of travel positions of components of a machine (10). The positions and velocities of the components of a machine (10) are determined at least in part based upon signals received from sensors (64) and command signals are generated to control movement of the components based upon input from an operator, proximate to the end of travel positions and the velocities of the components. Command signals are transmitted to control movement of the components. Multiple end of travel positions may also be defined.
Patent AU-2011334912-A1 (AU)
Title: Simple user-interface for a beverage machine
Inventor: MAISCH RAINER
IPC: A47J31/44
Filed: 2011-12-01
Abstract: A machine (1) for preparing a beverage comprises: an ingredient processing module (10) for processing at least one ingredient, in particular an ingredient supplied within a capsule (2) into the module; a sensing arrangement (70, 70' ) for sensing a user-request by a user-actuation of the sensing arrangement; and a control unit (60) containing different control programs for controlling the ingredient processing module executable on corresponding user-requests. The sensing arrangement (70, 70') and the control unit (60) are so arranged that each of said different user-requestable control programs is executed on a generally identical user-actuation of the sensing arrangement (70, 70' ).
Patent AU-2011335262-A1 (AU)
Title: Fabric conditioners
Inventor: CLOWES ELIZABETH ANN
IPC: C11D3/00
Filed: 2011-11-04
Abstract: An aqueous fabric conditioner composition comprising (a) from 2 to 9 wt % of a fabric softening active, by weight of the total composition, wherein the fabric softening active is an ester-linked quaternary ammonium compound having fatty acid chains comprising from 20 to 35 wt % of saturated C18 chains and from 20 to 35 wt % of monounsaturated C18 chains, by weight of total fatty acid chains; and (b) from 0.01 to 0.5 wt %, by weight of the total composition, of a floc prevention agent, which is a non-ionic alkoxylated material having an HLB value of from 8 to 18, wherein the aqueous fabric conditioner composition has a viscosity of greater than 50 cps, preferably from 55 to 200 cps as measured on a cup and bob viscometer; the viscosity being continuously measured under shear at 106s"1 for 60 seconds, at 25°C and wherein the composition leads to little or no floc formation upon addition to water.
Patent AU-2011336399-A1 (AU)
Title: System and method for lender directed voting
Inventor: BLOUNT EDMON W
IPC: G06F11/00
Filed: 2011-12-02
Abstract: Systems and methods for assigning a company's proxies associated with a company's shares from a financial intermediary to a lender are disclosed. In accordance with an aspect of the invention a system includes a memory and a processor. The memory stores a number of the company's shares for which the financial intermediary has not received proxy voting instructions and, for a plurality of lenders, the number of the company's shares loaned by the lender. The processor has access to the memory and determines a number of the company's proxies for which the financial intermediary has not received proxy voting instructions to assign to at least some of the plurality of lenders based on the number of company's shares for which the financial intermediary has not received voting instructions and based on the number of shares loaned by the lender.